Coloplast A/S (CLPBY)
7.26
+0.02
(+0.28%)
USD |
OTCM |
Aug 25, 16:00
Coloplast EPS Diluted (Quarterly) : 0.1009 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1009 |
| March 31, 2026 | -0.0675 |
| December 31, 2025 | 0.0966 |
| September 30, 2025 | 0.0608 |
| June 30, 2025 | 0.0543 |
| March 31, 2025 | 0.0571 |
| December 31, 2024 | 0.0663 |
| September 30, 2024 | 0.086 |
| June 30, 2024 | 0.0818 |
| March 31, 2024 | 0.0811 |
| December 31, 2023 | 0.08 |
| September 30, 2023 | 0.0798 |
| June 30, 2023 | 0.0874 |
| March 31, 2023 | 0.0784 |
| December 31, 2022 | 0.0727 |
| September 30, 2022 | 0.0784 |
| June 30, 2022 | 0.0867 |
| March 31, 2022 | 0.0694 |
| December 31, 2021 | 0.087 |
| September 30, 2021 | 0.097 |
| June 30, 2021 | 0.0953 |
| March 31, 2021 | 0.0858 |
| December 31, 2020 | 0.0854 |
| September 30, 2020 | 0.0766 |
| June 30, 2020 | 0.069 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0737 |
| December 31, 2019 | 0.0759 |
| September 30, 2019 | 0.0554 |
| June 30, 2019 | 0.0755 |
| March 31, 2019 | 0.0727 |
| December 31, 2018 | 0.0713 |
| September 30, 2018 | 0.0763 |
| June 30, 2018 | 0.0715 |
| March 31, 2018 | 0.0713 |
| December 31, 2017 | 0.0699 |
| September 30, 2017 | 0.075 |
| June 30, 2017 | 0.0635 |
| March 31, 2017 | 0.0628 |
| December 31, 2016 | 0.0646 |
| September 30, 2016 | 0.03 |
| June 30, 2016 | 0.0698 |
| March 31, 2016 | 0.0637 |
| December 31, 2015 | 0.0568 |
| September 30, 2015 | -0.1002 |
| June 30, 2015 | 0.0492 |
| March 31, 2015 | 0.0576 |
| December 31, 2014 | 0.0628 |
| September 30, 2014 | 0.07 |
| June 30, 2014 | 0.0679 |
| March 31, 2014 | -0.0017 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ambu A/S | 0.0711 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 227.46M |
| Revenue (Quarterly) | 1.144B |
| Total Expenses (Quarterly) | 916.84M |
| Enterprise Value | 18.57B |
| Gross Profit Margin (Quarterly) | 66.73% |
| Profit Margin (Quarterly) | 19.88% |
| Earnings Yield | 2.63% |
| Operating Earnings Yield | 7.12% |
| Normalized Earnings Yield | 4.747 |